missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Modotuximab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Marca: Invitrogen™ MA559489
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).
Specifica
| Modotuximab Chimeric | |
| Recombinant Monoclonal | |
| Unconjugated | |
| DS 1024; ERBB1 domain III; Sym 004 (combination of modotuximab and futuximab) | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto